Gene therapy treatment for AMD in clinical trials

Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]

New Drug for Dry Macular Degeneration?

A new drug to treat the “dry” form of macular degeneration is currently undergoing clinical trials. Allegro Ophthalmics has reported encouraging results from the phase 2 study of Risuteganib. The small phase 2 study involved 40 patients and was conducted over a 28 week period with participants receiving 2 injections. Half of the patients received […]

New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, BeovuĀ®, for the treatment of wet age-related macular degeneration (AMD). BeovuĀ® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Which Sunglasses Best Protect Your Vision?

While sunglasses are often deemed to be no more than a fashion accessory, the impact that they have on your vision is critically important. The choice of your sunglasses is every bit as important as your choice of sun block for your skin. The National Eye Institute reports that UV radiation can damage proteins in […]

Air pollution a factor in macular degeneration

Study results recently published in the Journal of Investigative Medicine point to a link between air pollutants and an increased risk of developing age-related macular degeneration. This is the first study to show a notable association between macular degeneration and high levels of atmospheric pollution. The study was conducted in Taiwan and involved tracking levels […]

Which is it? Calcium does or doesn’t increase macular degeneration risk?

A previous study pointed to high daily calcium dosage being linked to increased risk of macular degeneration, a potentially blinding condition of the eye. But a new National Institutes of Health study states that calcium supplementation is not a risk. So who are we to believe? It’s an important issue, because more than 40% of […]

Breakthrough Macular Degeneration research announced

Researchers at the University of California – Berkeley have found a way to treat eye diseases such as macular degeneration by turning ganglion cells into cells that can sense light. Many degenerative eye diseases are caused by photoreceptors that no longer work correctly. This new technique eliminates the need for photoreceptor cells. Using an inactivated […]

Gene therapy used to treat AMD

A surgeon at the John Radcliffe Hospital in the UK successfully injected a synthetic gene into a patient’s eye in the hope of stopping the progression of age-related macular degeneration. The patient, Janet Osborne, is the first person to receive the gene therapy in the trial that is being conducted at the John Radcliffe Hospital […]

Oranges reduce AMD risk 60%

Forget an apple a day to keep the doctor away, reach for an orange as a recent study shows that eating an orange a day can reduce your risk of developing late macular degeneration by as much as 60 percent. The flavonoids found in oranges provide a special protection against age-related macular degeneration. Researchers at […]

Implantable Lucentis means fewer injections for wet macular degeneration

Fewer Injections for Wet Macular Degeneration? A tiny implantable device for the treatment of macular degeneration is in clinical trials and may be approved by the FDA. The device will lessen the burden of patients who currently must endure injections on a monthly basis to treat their wet form of macular degeneration. This breakthrough device […]